drugset / Trial / NCT04567225

Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management

NCT04567225 ↗

Phase 4 Terminated 39 enrolled The Cleveland Clinic
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management

Timeline

Start
2020-10-01
Primary completion
2021-08-27
Completion
2021-08-27

Outcome

Outcome not reported

Stopped: “Stopped after internal review”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin glargine Protein / enzyme biologic 0.4 iu/kg Subcutaneous